Altruista Health

After a comprehensive review, the U.S. Consumer Product Safety Commission and Health Canada announced that they have found no cause linking Pampers Dry Max diapers and reports of diaper rash and other skin conditions. Pampers has welcomed the Commission's and Health Canada's thorough review and cooperated fully with them. "We are thankful that the U.S. CPSC and Health Canada conducted their thorough reviews and have not identified any cause for concern with Pampers with Dry Max," said Jodi Allen, Vice President of Pampers...

School children who consume foods purchased in vending machines are more likely to develop poor diet quality - and that may be associated with being overweight, obese or at risk for chronic health problems such as diabetes and coronary artery disease, according to research from the University of Michigan Medical School. The study also looked at foods sold in school stores, snack bars and other related sales that compete with USDA lunch program offerings and found that these pose the same health and diet risks in school-aged children...

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues...

AstraZeneca announced that the European Commission (EC) has issued a positive decision for the approval of once-daily SEROQUEL XR (quetiapine fumarate) Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. This decision follows a positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) in April of this year. AstraZeneca will now move forward in obtaining local approvals...

Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tablets will be registered in Australia under the trade name Movectro®. "Approval of Cladribine Tablets in Australia is another step forward in our commitment to fight the devastating disease of multiple sclerosis by providing new therapeutic options meeting unmet needs," said Elmar Schnee, Member of the Executive Board and Head of the Merck Serono division...

Tibotec Pharmaceuticals announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in treatment-naïve HIV-1-infected adults. It is estimated that 33.4 million people are living with HIV worlsudwide,[1] 2.3 million of which are in Europe...

As the FDA oversaw a massive egg recall for possible salmonella contamination, most Americans were aware of the outbreak and substantial numbers took steps to protect themselves from getting sick, according to a new national poll by researchers at Harvard School of Public Health (HSPH). The poll was conducted August 27-30, 2010. As of August 24, 2010, the Centers for Disease Control and Prevention (CDC) had identified approximately 1,469 reported illnesses nationwide that were likely to be associated with this outbreak...

The American Red Cross is responding with help to people affected by the winds, rains and flooding of Hurricane Earl in North Carolina and is ready as the storm moves up the Atlantic Coast. A dozen Red Cross shelters were opened in North Carolina, giving more than 260 a safe place to ride out the storm last night as heavy rain and strong winds passed through the area. Today, after Earl moves out of the area, the Red Cross will be assessing damage left by the storm and helping people as they begin to cleanup...

GSK initially became aware of possible cases of narcolepsy following vaccination with the adjuvanted H1N1 pandemic vaccine Pandemrix through adverse event reports received by the Swedish Medical Products Agency, and subsequently via media reports in Finland. Information on the individual cases remains limited at present, but GSK is conducting its own investigation in an effort to gather as much additional data as possible regarding the reported cases, and is working closely with key regulatory authorities, including the European Medicines Agency (EMA)...

Lineagen, Inc., a developer of innovative genomic tests and services for the screening, evaluation and diagnosis of complex disorders and diseases including autism spectrum disorders, announced today that Dr. Michael S. Paul, the Company's President & Chief Executive Officer, was selected to present at the "Genetic Risk Factors for Autism: Translating Discoveries into Diagnostics" symposium, being held September 1-2, 2010 at the Old Mill Inn and Spa in Toronto, Ontario, Canada...